Combining an antibiotic drug that targets glutamine with the ketogenic diet helps kill glioblastoma cancer cells, reversing symptoms of the disease and improving survivability in mouse models.
Researchers have discovered a key to glioblastoma tumor cells proliferation, and ways to turn this engine of tumor growth into a target for cancer treatment.
Study shows how cholesterol becomes dysregulated in brain cancer cells and reports the gene responsible for the dysregulation could be a potential target to help treat glioblastoma brain cancer.
Study reveals how two key molecules, Rab27b, and epiregulin, interact to contribute to radioresistance in glioblastoma brain cancer.
Researchers have developed a new drug that could help prolong the lives of people with glioblastoma brain cancer.
A lipid nanocarrier small enough to pass the blood-brain barrier could be an effective method for delivering chemotherapy medications to help fight glioblastoma brain tumors, a new study reports.
When aggressive, malignant tumors appear in more than one location in the brain, patient survival tends to be significantly shorter than when the disease starts as a single tumor, even though patients in both groups undergo virtually identical treatments, according to research at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Research Institute.
Newly released map of glioblastoma brain cancer could help researchers find new cures for deadly disease.
Researchers are developing nanocarriers that are twice as effective as liposomes at reaching glioblastoma brain tumors.
According to a new study, neural activity can stimulate the growth of high-grade glioma brain cancers.
A new study reports researchers have identified a mechanism that aids the growth of glioblastoma brain cancer. By blocking the mechanism, researchers were able to halt the progression of the tumors.
Targeting a protein called neuroligin 3 helps stop the growth of high grade gliomas in mice, a new study reports.
